| Timing of abuse | |||||
---|---|---|---|---|---|---|
Childhood-only | Adolescence-only | ‘Persistent’ | ||||
 | OR | 95% CI | OR | 95% CI | OR | 95% CI |
Weighted | ||||||
 Lowa | ||||||
  CL | 1.44 | 0.49–4.18 | 0.70 | 0.21–2.35 | 1.24 | 0.41–3.75 |
  AO | 3.98 | 1.40–11.34 | 2.72 | 0.97–7.57 | 7.51 | 3.42–16.48 |
  EOP | 6.17 | 2.39–15.94 | 2.89 | 0.81–10.32 | 9.80 | 4.45–21.58 |
 CLa | ||||||
  AO | 2.77 | 0.48–15.98 | 3.87 | 0.62–24.28 | 6.04 | 1.30–28.15 |
  EOP | 4.29 | 0.97–18.97 | 4.12 | 0.64–26.60 | 7.89 | 1.89–32.98 |
 AOa | ||||||
  EOP | 1.55 | 0.39–6.13 | 1.06 | 0.20–5.57 | 1.31 | 0.42–4.02 |
Unweighted | ||||||
 Lowa | ||||||
  CL | 1.65 | 0.76–3.60 | 0.92 | 0.34–2.44 | 0.98 | 0.33–2.97 |
  AO | 3.24 | 1.27–8.26 | 2.50 | 0.97–6.45 | 6.48 | 3.31–12.68 |
  EOP | 3.94 | 1.71–9.02 | 1.99 | 0.67–5.86 | 6.75 | 3.49–13.06 |
 CLa | ||||||
  AO | 1.96 | 0.50–7.69 | 2.73 | 0.56–13.34 | 6.59 | 1.53–28.34 |
  EOP | 2.38 | 0.75–7.56 | 2.17 | 0.49–9.66 | 6.87 | 1.77–26.72 |
 AOa | ||||||
  EOP | 1.21 | 0.35–4.17 | 0.79 | 0.18–3.49 | 1.04 | 0.42–2.61 |